X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib

NCT03215693 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: X-396 capsule

Sponsor

Betta Pharmaceuticals Co., Ltd.